BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 18580502)

  • 1. Effect of stimulants on height and weight: a review of the literature.
    Faraone SV; Biederman J; Morley CP; Spencer TJ
    J Am Acad Child Adolesc Psychiatry; 2008 Sep; 47(9):994-1009. PubMed ID: 18580502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?
    Spencer TJ; Biederman J; Harding M; O'Donnell D; Faraone SV; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1460-9. PubMed ID: 8936912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health.
    Moungnoi P; Maipang P
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S158-63. PubMed ID: 22043770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulant treatment over 5 years: effects on growth.
    Charach A; Figueroa M; Chen S; Ickowicz A; Schachar R
    J Am Acad Child Adolesc Psychiatry; 2006 Apr; 45(4):415-21. PubMed ID: 16601646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does extended medication with amphetamine or methylphenidate reduce growth in hyperactive children?
    Sund AM; Zeiner P
    Nord J Psychiatry; 2002; 56(1):53-7. PubMed ID: 11869467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth deficits in children with attention deficit hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Pediatrics; 1998 Aug; 102(2 Pt 3):501-6. PubMed ID: 9685453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and sexual maturation in children and adolescents with attention deficit hyperactivity disorder.
    Poulton A
    Curr Opin Pediatr; 2006 Aug; 18(4):427-34. PubMed ID: 16914999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD.
    Zhang H; Du M; Zhuang S
    Neuropediatrics; 2010 Aug; 41(2):55-9. PubMed ID: 20799150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth on stimulant medication; clarifying the confusion: a review.
    Poulton A
    Arch Dis Child; 2005 Aug; 90(8):801-6. PubMed ID: 16040876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth deficits in children treated with desipramine: a controlled study.
    Spencer T; Biederman J; Wright V; Danon M
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):235-43. PubMed ID: 1564024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.
    Schertz M; Adesman AR; Alfieri NE; Bienkowski RS
    Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term psychostimulant medication on growth of children with ADHD.
    Zachor DA; Roberts AW; Hodgens JB; Isaacs JS; Merrick J
    Res Dev Disabil; 2006; 27(2):162-74. PubMed ID: 15955659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
    Merkel RL; Kuchibhatla A
    Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of osmotic-release methylphenidate on height and weight in children with attention-deficit hyperactivity disorder (ADHD) following up to four years of treatment.
    Durá-Travé T; Yoldi-Petri ME; Gallinas-Victoriano F; Zardoya-Santos P
    J Child Neurol; 2012 May; 27(5):604-9. PubMed ID: 22190507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of methylphenidate on height and weight in Korean children and adolescents with attention-deficit/hyperactivity disorder: a retrospective chart review.
    Kim HW; Kim SO; Shon S; Lee JS; Lee HJ; Choi JH
    J Child Adolesc Psychopharmacol; 2014 Oct; 24(8):448-53. PubMed ID: 25285915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth in stimulant-naive children with attention-deficit/hyperactivity disorder using cross-sectional and longitudinal approaches.
    Hanć T; Cieślik J
    Pediatrics; 2008 Apr; 121(4):e967-74. PubMed ID: 18381524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.